183 related articles for article (PubMed ID: 8260696)
1. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
[TBL] [Abstract][Full Text] [Related]
2. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of heme and IL-1 on hematopoietic stromal regeneration after radiation.
Lutton JD; Chertkov JL; Jiang S; Kappas A; Levere RD; Abraham NG
Am J Hematol; 1993 Nov; 44(3):172-8. PubMed ID: 8213766
[TBL] [Abstract][Full Text] [Related]
5. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
Gallicchio VS; Hughes NK
Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625
[TBL] [Abstract][Full Text] [Related]
6. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
Chow FP; Sutton PA; Hamburger AW
Br J Haematol; 1991 Feb; 77(2):139-44. PubMed ID: 2004015
[TBL] [Abstract][Full Text] [Related]
8. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
9. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
10. Hemotoxic effects on mice of combined administration of azidothymidine and acyclovir.
Bogliolo G; Lerza R; Mencoboni M; Flego G; Gasparini L; Pannacciulli I
Exp Hematol; 1991 Sep; 19(8):838-41. PubMed ID: 1868898
[TBL] [Abstract][Full Text] [Related]
11. Effect of blood substitute, recombinant hemoglobin, on in vivo hematopoietic recovery from AZT toxicity.
Moqattash S; Lutton JD; Rosenthal G; Abu-Hijleh MF; Abraham NG
Acta Haematol; 1997; 98(2):76-82. PubMed ID: 9286303
[TBL] [Abstract][Full Text] [Related]
12. Failure of stem cell factor to ameliorate AZT-induced anemia in immunodeficient mice.
Hamburger AW; Zsebo K; Chow FP
Eur J Haematol; 1993 Mar; 50(3):172-8. PubMed ID: 7682517
[TBL] [Abstract][Full Text] [Related]
13. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
14. In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine.
Gallicchio VS; Hughes NK; Tse KF
Cytokine; 1993 Jan; 5(1):62-71. PubMed ID: 8485306
[TBL] [Abstract][Full Text] [Related]
15. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
[TBL] [Abstract][Full Text] [Related]
16. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
[TBL] [Abstract][Full Text] [Related]
17. Specificity of heme for hemopoietic recovery from AZT toxicity.
Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
[TBL] [Abstract][Full Text] [Related]
18. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1.
Gallicchio VS; Doukas MA; Hulette BC; Hughes NK; Gass C
Proc Soc Exp Biol Med; 1989 Nov; 192(2):201-4. PubMed ID: 2813453
[TBL] [Abstract][Full Text] [Related]
19. In vitro improvement of bone marrow-derived hematopoietic colony formation in HIV-positive patients by alpha-D-tocopherol and erythropoietin.
Geissler RG; Ganser A; Ottmann OG; Gute P; Morawetz A; Guba P; Helm EB; Hoelzer D
Eur J Haematol; 1994 Oct; 53(4):201-6. PubMed ID: 7957803
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
